#hcb101

Live, measured metrics for the hashtag #hcb101 from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #hcb101

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$520.70/ year · 6-character #name
Claim #hcb101 — $520.70/yr→Buy on hashtag.space (web3)
card via hashtag.org · tokens via hashtag.space
0
Uses / 7 days
Mastodon
0
Accounts / 7 days
Mastodon
1
Recent posts
Mastodon
—
Recent pace
Mastodon · last 1
0
Avg reactions / post
Mastodon · last 1

Day-by-day usage

measured · fosstodon.org (Mastodon public tags API) · fetched 2026-07-27 17:17 UTC
0
07-21
0
07-22
0
07-23
0
07-24
0
07-25
0
07-26
0
07-27

0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · fosstodon.org (Mastodon public search API) · fetched 2026-07-27 17:17 UTC

No related tags with measured usage found for #hcb101.

Live pulse

measured · fosstodon.org (Mastodon tag timeline) · fetched 2026-07-27 17:17 UTC

Everything below is measured over the latest 1 public posts.

Posting hours (UTC)

00:0012:0023:00

Avg boosts / post: 0

Top of the latest posts

  • AI時代新藥設計：漢康生技如何用「蛋白質工程」，賭一個45億美元授權？林昆輝（Quinn Lin） 2026-07-12 07:58:00 CST漢康的CD47新藥HCB101，運用AI輔助蛋白質工程，突破前代藥物安全性與療效的兩難，能高選擇性攻擊腫瘤而不傷紅血球，目標在完成概念驗證後進行國際授權。 https://www.thenewslens.com/article/269119 #蛋白質工程 #免疫系統 #AI輔助蛋白質工程 #腫瘤細胞 #FDA #巨噬細胞 #商業 #

    The News Lens@[email protected]♥ 0↻ 02026-07-12 00:29 UTCView post →

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/hcb101